31 results
DEF 14A
NMRA
Neumora Therapeutics Inc.
25 Apr 24
Definitive proxy
4:05pm
of the SEC and Nasdaq. Our Board has determined that Mr. Fust is an audit committee financial expert as defined under the applicable rules of the SEC
10-K
2023 FY
EX-10.22
NMRA
Neumora Therapeutics Inc.
7 Mar 24
Annual report
4:05pm
. The arbitrator shall award the prevailing Party attorneys’ fees and expert fees, if any. Notwithstanding the foregoing, it is acknowledged
8-K
EX-99.1
NMRA
Neumora Therapeutics Inc.
8 Jan 24
Regulation FD Disclosure
8:32am
programs to potentially increase the expert company builders and neuroscience drug developers in areas of significant unmet need odds of clinical success
424B4
NMRA
Neumora Therapeutics Inc.
18 Sep 23
Prospectus supplement with pricing info
4:12pm
-party valuation expert. Such estimates involve inherent uncertainties and the application of significant judgment. As a result, if factors or expected … is an “audit committee financial expert” within the meaning of the SEC rules. This designation does not impose on such directors any duties, obligations
S-1/A
NMRA
Neumora Therapeutics Inc.
11 Sep 23
IPO registration (amended)
6:07am
expert. Such estimates involve inherent uncertainties and the application of significant judgment. As a result, if factors or expected outcomes change … Fust is an “audit committee financial expert” within the meaning of the SEC rules. This designation does not impose on such directors any duties
S-1/A
EX-10.13
2104t32ix
11 Sep 23
IPO registration (amended)
6:07am
S-1
EX-2.1
9ajez1u
25 Aug 23
IPO registration
5:03pm
S-1
EX-10.11
u8kvqpt
25 Aug 23
IPO registration
5:03pm
S-1
80a11lb 7fa6t5qca0
25 Aug 23
IPO registration
5:03pm
S-1
EX-10.15
t2leo50 ay3uu
25 Aug 23
IPO registration
5:03pm
S-1
EX-2.2
g2j4ommij8mia78ut7eo
25 Aug 23
IPO registration
5:03pm
S-1
EX-10.9
cadnwg vw
25 Aug 23
IPO registration
5:03pm
S-1
EX-10.10
8nluw1
25 Aug 23
IPO registration
5:03pm
S-1
EX-10.16
zpk5nscttve7bhebgxg
25 Aug 23
IPO registration
5:03pm
S-1
EX-10.20
kov32138
25 Aug 23
IPO registration
5:03pm
S-1
EX-10.5
ke21rbi
25 Aug 23
IPO registration
5:03pm
DRS/A
t99jfjn748iv9m2
9 Aug 23
Draft registration statement (amended)
12:00am
DRS/A
EX-10.21
i5vay
9 Aug 23
Draft registration statement (amended)
12:00am
DRS/A
7mto 6txn4sp
30 Jun 23
Draft registration statement (amended)
12:00am
DRS/A
EX-10.10
cji02plqu86ceepyhnhn
30 Jun 23
Draft registration statement (amended)
12:00am